InvestorsHub Logo

Wildbilly

01/23/20 9:20 AM

#806 RE: biocqr #805

...and presently $3.56 pm lol.

vinmantoo

01/23/20 11:56 AM

#807 RE: biocqr #805

Trillium Therapeutics (NASDAQ:TRIL) has priced its public offering of 35,731,818 common shares and 1,250,000 Series II Non-Voting Convertible First Preferred Shares, both at $2.75 per share, for expected gross proceeds of $101.7M.



A good chunk of change without being overly dilutive. I believe this offering alone is for some 3x more cash than TRIL had on hand. Good news!